Federal Member for Wright, Scott Buchholz MP has welcomed the Coalition Government’s decision to make a medication for severe inflammatory spinal arthritis more affordable for local patients saving more than $15,000 a year.
Almost 4,000 patients across Australia who are suffering from active non-radiographic axial spondyloarthritis will benefit when Simponi® (Golimumab) becomes available on the PBS on December 1.
Scott Buchholz said patients would have had pay over $1,300 per script will only pay a maximum of $39.50 per script, or only $6.40 if they have a concession card.
“The Coalition Government has also negotiated immediate compassionate for patients meaning those who need it most will have access to the medication without having to wait until it’s listed on the PBS,
“Simponi® helps reduce inflammation, swelling and joint destruction for some patients, by blocking inflammation through changes to the patient’s immune system.” Mr Buchholz said.
“This listing will save families thousands of dollars and help patients manage their condition and improve their quality of life.”
Scott Buchholz said since coming into Government, the Coalition has helped improve the health of Australians by subsidising $9.7 billion worth of new medicines. This means an average of around 31 listings per month or one per day.
“In the Budget we announced our commitment to invest $2.4 billion on new medicines to build on our commitment to guarantee those essential services that all Australians rely on.”
“Our commitment to the PBS is rock solid. Together with Medicare, it is a foundation of our world-class health care system.”